Search Within

Matteo Repetto

Formats
  1. Journal Article (9)
  2. Meeting Abstract (9)
  3. Review (7)
  4. Editorial (1)
Groups
  1. Sloan Kettering Institute Postdocs (26)
  2. Department of Medicine (18)
  3. Solid Tumor Oncology Division (18)
  4. Graduate Medical Education (15)
  5. Thoracic Oncology (15)
  6. Department of Pathology and Laboratory Medicine (13)

More Groups

People
  1. Alexander Drilon (15)
  2. Andrea Gazzo (7)
  3. Britta Weigelt (7)
  4. Pier Selenica (6)
  5. Mark Donoghue (5)
  6. Soo Ryum Yang (5)

More People

Years
  1. 2025 (4)
  2. 2024 (16)
  3. 2023 (6)
Publications
  1. Journal of Clinical Oncology (4)
  2. Laboratory Investigation (4)
  3. The Oncologist (3)
  4. Cancers (2)
  5. Annals of Oncology (1)
  6. Breast Cancer Research and Treatment (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. Nature Publishing Group (5)
  3. Oxford University Press (4)
  4. Elsevier Inc. (2)
  5. MDPI (2)
  6. Adis International Ltd (1)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diverging acquired resistance evolutionary pathways in fusion-positive patients treated with tyrosine kinase inhibitors
    Meeting Abstract

    Repetto, M.; Selenica, P.; Gazzo, A.; Richards, A. L.; Reis-Filho, J. S.; Jee, J.; Donoghue, M.; Weigelt, B.; Drilon, A. E.; Choudhury, N. J.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A pan-cancer analysis of SMARCA4 alterations and the unique clinicogenomic characteristics associated with SMARCA4 mutation types
    Meeting Abstract

    Gormally, M.; Repetto, M.; Jee, J.; Chang, J. C.; Selenica, P.; Gazzo, A.; Richards, A. L.; Donoghue, M.; Aghajanian, C.; Reis-Filho, J. S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Germline and somatic MUTYH mutations: Clinicopathologic and mutational analysis in a pan-cancer cohort
    Meeting Abstract

    Desilets, A.; Repetto, M.; Kemel, Y.; Khurram, A.; Mandelker, D.; Bandlamudi, C.; Novak, B.; Velilla, C.; Selenica, P.; Richards, A. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents
    Journal Article

    Roa, P.; Foglizzo, V.; Harada, G.; Repetto, M.; Kulick, A.; de Stanchina, E.; de Marchena, M.; Auwardt, S.; Sayed Ahmed, S.; Bremer, N. V.; more...
    British Journal of Cancer (2024)

    Fulltext@MSK | Save
  • TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers
    Journal Article

    Thawani, R.; Repetto, M.; Keddy, C.; Nicholson, K.; Jones, K.; Nusser, K.; Beach, C. Z.; Harada, G.; Drilon, A.; Davare, M. A.
    npj Precision Oncology (2024)

    Fulltext@MSK | Save
  • Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers
    Journal Article

    Belli, C.; Boscolo Bielo, L.; Repetto, M.; Crimini, E.; Scalia, R.; Diana, A.; Orefice, J.; Ascione, L.; Pellizzari, G.; Fusco, N.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis
    Journal Article

    Bielo, L. B.; Repetto, M.; Crimini, E.; Belli, C.; Setola, E.; Parma, G.; Fusco, N.; Barberis, M.; Rocco, E. G.; Marra, A.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Cancers of unknown primary origin: Real-world clinical outcomes and genomic analysis at the European Institute of Oncology
    Journal Article

    Boscolo Bielo, L.; Belli, C.; Crimini, E.; Repetto, M.; Ascione, L.; Pellizzari, G.; Santoro, C.; Fuorivia, V.; Barberis, M.; Fusco, N.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • NTRK gene fusion testing and management in lung cancer
    Review

    Repetto, M.; Chiara Garassino, M.; Loong, H. H.; Lopez-Rios, F.; Mok, T.; Peters, S.; Planchard, D.; Popat, S.; Rudzinski, E. R.; Drilon, A.; more...
    Cancer Treatment Reviews (2024)

    Fulltext@MSK | Save
  • Beyond PD(L)-1 blockade in microsatellite-instable cancers: Current landscape of immune co-inhibitory receptor targeting
    Review

    Crimini, E.; Boscolo Bielo, L.; Berton Giachetti, P. P. M.; Pellizzari, G.; Antonarelli, G.; Taurelli Salimbeni, B.; Repetto, M.; Belli, C.; Curigliano, G.
    Cancers (2024)

    Fulltext@MSK | Save